Another Choice for Prevention of COPD Exacerbations

N Engl J Med. 2016 Jun 9;374(23):2284-6. doi: 10.1056/NEJMe1604444. Epub 2016 May 15.

Author

James F Donohue¹

Affiliation

¹ From the Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill.

PMID: 27181835
DOI: 10.1056/NEJMe1604444

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adrenergic beta-2 Receptor Agonists / therapeutic use*
Female
Fluticasone-Salmeterol Drug Combination / therapeutic use*
Glucocorticoids / therapeutic use*
Glycopyrrolate / therapeutic use*
Humans
Indans / therapeutic use*
Male
Muscarinic Antagonists / therapeutic use*
Pulmonary Disease, Chronic Obstructive / drug therapy*
Quinolones / therapeutic use*

Substances

Adrenergic beta-2 Receptor Agonists
Fluticasone-Salmeterol Drug Combination
Glucocorticoids
Indans
Muscarinic Antagonists
Quinolones
indacaterol
Glycopyrrolate